1.png)
.png){kind=small}
Pengetahuan Infeksi Human Papilomavirus dan Skrining Kanker Serviks Pada Perempuan Usia Produktif
Abstract
Kanker serviks menjadi masalah kesehatan reproduksi pada perempuan dan kasus paling umum di seluruh dunia pada perempuan. Pertumbuhan sel prakanker dipicu oleh infeksi Human Papillomavirus (HPV) dikaitkan dengan perkembangan kanker serviks. Pengetahuan perempuan tentang infeksi HPV dan skrining kanker serviks perlu diterapkan untuk mengatasi keterlambatan diagnosis. Tujuan penelitian untuk menganalisa pengetahuan infeksi HPV dan skrining kanker serviks pada perempuan usia produktif. Penelitian cross-sectional yang dilakukan terhadap 186 responden di wilayah Puskesmas Piyungan Bantul. Analisis univariat untuk memberikan informasi deskriptif dari setiap variabel penelitian. Instrumen penelitian menggunakan kuesioner pengetahuan infeksi HPV yang terdiri dari 5 item pertanyaan dengan nilai skor total 0-5. Kuesioner pengetahuan tentang skrining kanker serviks terdiri dari 14 item pertanyaan dengan nilai skor maksimal 0-14. Hasil penelitian menunjukkan pengetahuan perempuan usia produktif mengenai infeksi HPV terbanyak pada kategori pengetahuan kurang yaitu 115 responden (61,83%). Sedangkan pengetahuan perempuan usia produktif mengenai skrining kanker serviks terbanyak pada kategori pengetahuan yang rendah sejumlah 107 responden (57,53%). Disimpulkan bahwa perempuan usia produktif memiliki pengetahuan kurang tentang skrining kanker serviks dan pengetahuan kurang tentang infeksi HPV dengan p-value 0,029 sehingga dikatakan bermakna. Pendekatan upaya promotif dan preventif menjadi penting untuk pengendalian infeksi HPV dan keberhasilan skrining.
Keywords
Full Text:
PDFReferences
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Heal. 2020;8(2):e191–203.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Purnamasari D. The Emergence of Non-communicable Disease in Indonesia. Acta Med Indones. 2018;50(4):273–4.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–89.
Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–4.
World Health Organization. Cervical Cancer Elimination Initiative [Internet]. WHO Press. 2023 [cited 2024 Apr 15]. p. 1. Available from: https://www.who.int/initiatives/cervical-cancer-elimination-initiative
Bruni L, Serrano B, Raura E, Aemani L, Cowan M, Herero R. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis [Internet]. The Lancet Global Health. 2022 [cited 2024 Apr 12]. p. 1. Available from: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00241-8/fulltext
Kaufman HW, Alagia DP, Chen Z, Onisko A, Marshall Austin R. Contributions of liquid-Based (Papanicolaou) cytology and human papillomavirus testing in cotesting for detection of cervical cancer and precancer in the united states. Am J Clin Pathol. 2020;154(4):510–6.
Gu L, Hu Y, Wei Y, Hong Z, Zhang Y, Lin J, et al. Optimising cervical cancer screening during pregnancy: A study of liquid-based cytology and HPV DNA co-test. Epidemiol Infect. 2024;152(1):4–9.
WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) [Internet]. WHO Press. 2021. 63 p. Available from: https://www.who.int/publications/i/item/9789240030824
NIH. ACS’s Updated Cervical Cancer Screening Guidelines Explained [Internet]. 2020 [cited 2024 Apr 22]. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2020/cervical-cancer-screening-hpv-test-guideline
Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321–46.
Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE. Acceptability and Usability of Self-Collected Sampling for HPV Testing Among African-American Women Living in the Mississippi Delta. Women’s Heal Issues. 2013;23(2):123–30.
WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. World Health Organization. 2024 [cited 2024 Mar 23]. Available from: https://www.who.int/publications/i/item/9789240014107
Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health [Internet]. 2015;15(1):1–7. Available from: ???
Jongen C, McCalman J, Bainbridge R. Health workforce cultural competency interventions: A systematic scoping review. BMC Health Serv Res. 2018;18(1):1–15.
National Institute of Health. Understanding Cervical Changes. National Cancer Institute. 2021. 1–20 p.
Shepherd MA, Gerend MA. The blame game: Cervical cancer, knowledge of its link to human papillomavirus and stigma. Psychol Heal. 2014;29(1):94–109.
Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, et al. “Easy women get it”: pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program. BMC Public Health. 2023;23(1):1–13.
Ginjupalli R, Mundaden R, Choi Y, Herfel E, Oketch SY, Watt MH, et al. Developing a framework to describe stigma related to cervical cancer and HPV in western Kenya. BMC Womens Health [Internet]. 2022;22(1):1–9. Available from: https://doi.org/10.1186/s12905-022-01619-y
Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, et al. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. J Women’s Heal. 2021;30(1):5–13.
Suk R, Hong YR, Rajan SS, Xie Z, Zhu Y, Spencer JC. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019. JAMA Netw Open. 2022;5(1):1–13.
Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;1–13.
Modibbo FI, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016;6(1):1–12.
Dinkes DIY. Bagaimana HPV di DIY? [Internet]. 2019 [cited 2024 Apr 2]. Available from: https://dinkes.jogjaprov.go.id/berita/detail/hpv-2019-program-imunisasi-kanker-serviks-human-papiloma-virus-sakit-bagaimana-hpv-di-diy
Dinkes DIY. Profil Kesehatan D.I. Yogyakarta Tahun 2022. Dinkes DIY. Yogyakarta: Dinkes DIY; 2023. 1–205 p.
Alsaad MA, Shamsuddin K, Fadzil F. Knowledge towards HPV infection and HPV vaccines among Syrian mothers. Asian Pacific J Cancer Prev. 2012;13(3):879–83.
Rahul Ganavadiya CSB, , Suma S2 , Pallavi Singh3 RG, Poonam Tomar Rana SJD. Effectiveness of two psychological intervention techniques Article for de‑addiction among patients with addiction to tobacco and alcohol – A double‑blind randomized control trial Rahul Ganavadiya, Chandra Shekar BR1 , Suma S2 , Pallavi Singh3 , Ruchika Gu. Indian J Cancer. 2018;55(1):382–9.
Al-Darwish AA, Al-Naim AF, Al-Mulhim KS, Al-Otaibi NK, Morsi MS, Aleem AM. Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia. Asian Pacific J Cancer Prev. 2014;15(6):2529–32.
Roik EE, Sharashova EE, Nieboer E, Kharkova OA, Postoev VA, Odland J. Knowledge about human papillomavirus and prevention of cervical cancer among women of Arkhangelsk, Northwest Russia. PLoS One. 2017;12(12):1–13.
Aragones A, Genoff M, Gonzalez C, Shuk E, Gany F. HPV Vaccine and Latino Immigrant Parents: If They Offer It, We Will Get It. J Immigr Minor Heal. 2016;18(5):1060–5.
Omer SB, Orenstein WA, Koplan JP. Go Big and Go Fast — Vaccine Refusal and Disease Eradication. N Engl J Med. 2013;368(15):1374–6.
Cartwright K, Kosich M, Gonya M, Kanda D, Leekity S, Sheche J, et al. Cervical Cancer Knowledge and Screening Patterns in Zuni Pueblo Women in the Southwest United States. J Cancer Educ [Internet]. 2023;38(5):1531–8. Available from: https://doi.org/10.1007/s13187-023-02295-8
John-Akinola YO, Ndikom CM, Oluwasanu MM, Adebisi T, Odukoya O. Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review. Cancer Control. 2022;29:1–11.
Zewdie A, Shitu S, Kebede N, Gashaw A, Eshetu HB, Eseyneh T, et al. Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis. BMC Cancer [Internet]. 2023;23(1):1–9. Available from: https://doi.org/10.1186/s12885-023-11728-y
Morhason-Bello IO, Kareem YO, Adewole IF. Modeling for Predictors of Knowledge Score on Etiology and Prevention Strategies for Cervical Cancer Among Women of Reproductive Age in Ibadan. JCO Glob Oncol. 2020;(6):892–903.
Tuoheti Z, Han L, Husaiyin S, Liu X, Ma C, Niyazi M. RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China. BMC Cancer. 2020;20(1):1–7.
Revathidevi S, Kannan A, Nakaoka H, Inoue I, Munirajan AK. APOBEC : A molecular driver in cervical cancer pathogenesis. Cancer Lett. 2020;496(1):104–16.
Qiu L, Feng H, Yu H, Li M, You Y, Zhu S, et al. Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing. Genes (Basel). 2022;13(2).
Pandey NO, Chauhan A V., Raithatha NS, Patel PK, Khandelwal R, Desai AN, et al. Author correction: Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility. Sci Rep [Internet]. 2019;9(12):1. Available from: http://dx.doi.org/10.1038/s41598-019-55122-w
Mehrotra R, Yadav K. Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management. Indian J Gynecol Oncol [Internet]. 2022;20(1):1–8. Available from: https://doi.org/10.1007/s40944-021-00602-z
Forster AS, Rockliffe L, Marlow LAV, Bedford H, McBride E, Waller J. Exploring human papillomavirus vaccination refusal among ethnic minorities in England: A comparative qualitative study. Psychooncology. 2017;26(9):1278–84.
Hopfer S, Garcia S, Duong HT, Russo JA, Tanjasiri SP. A Narrative Engagement Framework to Understand HPV Vaccination Among Latina and Vietnamese Women in a Planned Parenthood Setting. Heal Educ Behav. 2017;44(5):738–47.
Grandahl M, Tydén T, Gottvall M, Westerling R, Oscarsson M. Immigrant women’s experiences and views on the prevention of cervical cancer: A qualitative study. Heal Expect. 2015;18(3):344–54.
Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Heal [Internet]. 2020;5(4):223–34. Available from: http://dx.doi.org/10.1016/S2468-2667(20)30010-4
Maharajan MK, Rajiah K, Num KSF, Yong NJ. Knowledge of human papillomavirus infection, cervical cancer and willingness to pay for cervical cancer vaccination among ethnically diverse medical students in Malaysia. Asian Pacific J Cancer Prev. 2015;16(14):5733–9.
Cinar I, Ozkan S, Aslan G, Alatas E. Knowledge and Behavior of University Students toward Human Papillomavirus and Vaccination. Asia-Pacific J Oncol Nurs. 2019;6(3):300–7.
Ararsa T, Tadele N, Ayalew Y, Gela D. Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey. BMC Cancer. 2021;21(1):1–9.
Siddharthar J, Rajkumar B, Deivasigamani K. Knowledge awareness and prevention of cervical cancer among women attending a tertiary care hospital in Puducherry, India. J Clin Diagnostic Res. 2014;8(6):8–10.
Kim JY, Lee DW, Kim MJ, Shin JE, Shin YJ, Lee HN. Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010–2018). BMC Cancer. 2021;21(1):1–6.
G N, M JS, G S, J DR, B PK, KV V. Knowledge, attitude, and practice toward cervical cancer among women attending Obstetrics and Gynecology Department: A cross-sectional, hospital-based survey in South India. Indian J Cancer. 2017;54:481–7.
El-Hosary E, Atia MM, Nady SE, Lobna E Sallam. The Effect of Constructed Psycho-educational Nursing Guidance on Married women’s Beliefs, Attitudes, and Preventive Practices of Cervical Cancer. Int Egypt J Nurs Sci Res. 2022;3(2):614–34.
DOI: https://doi.org/10.33085/jkg.v7i3.6096
Refbacks
- There are currently no refbacks.
Sponsored/Supported by:
Contact Person:
Jl. Kapt Sumarsono 107, Helvetia, Medan, Sumatera Utara - 20124, Indonesia.
Hp: +6282 3659 99629. Tel/Faks: (061) 42084606